Gala Pharmaceutical Inc. — key financial figures for fiscal year 2018 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2018)

$4.7K

Net Income/Loss (FY2018)

-$1.9M

Total Assets (FY2018)

$262.2K

Total Equity (FY2018)

-$858.7K

Cash Flows from Operating Activities (FY2018)

-$631.9K

Source: Gala Pharmaceutical Inc. 10-K filing (FY2018). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.